Curevac saw the highest growth of 249% in patent filings in January and 132% in grants in March in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 249% and grants by 124%. GlobalData’s DataBook provides a comprehensive analysis of Curevac‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Curevac has been focused on protecting inventions in United States(US) with 15 publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 36% filings and 50% grants. The United States(US), Japan(JP), European Patent Office(EPO), and Australia(AU) patent Office are among the top ten patent offices where Curevac is filings its patents. Among the top granted patent authorities, Curevac has 50% of its grants in United States(US), 8% in European Patent Office(EPO) and 8% in Australia(AU).

GSK and University of Pennsylvania could be the strongest competitors for Curevac

In terms of grant share, Curevac stands in fifth position among its competitors. GSK and University of Pennsylvania secured the top positions according to recent patent publication data.

Patents related to nanomedicine and rare diseases lead Curevac's portfolio

Curevac has the highest number of patents in nanomedicine followed by, rare diseases and Covid-19. For nanomedicine, nearly 41% of patents were filed and 35% of patents were granted in Q1 2024.

Severe acute respiratory syndrome (sars) related patents lead Curevac portfolio followed by respiratory syncytial virus (rsv) infections, and allergies

Curevac has highest number of patents in severe acute respiratory syndrome (sars) followed by respiratory syncytial virus (rsv) infections, allergies, coronaviridae infections, and coronavirus disease 2019 (covid-19). For severe acute respiratory syndrome (sars), nearly 9% of patents were filed and 15% of patents were granted in Q1 2024.

For comprehensive analysis of Curevac's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.